Literature DB >> 16934243

Capture of flowing human neutrophils by immobilised immunoglobulin: roles of Fc-receptors CD16 and CD32.

Christopher A Skilbeck1, Xiaomei Lu, Sajila Sheikh, Caroline O S Savage, Gerard B Nash.   

Abstract

We investigated capture and activation of flowing human neutrophils through their Fc-receptors, FcRgammaIIIB (CD16) and FcRgammaIIA (CD32). Immobilised platelets bearing murine monoclonal antibody against glycoprotein IIbIIIA were able to capture and activate flowing neutrophils. The activation response was inhibited by antibody blockade of neutrophil CD32. However, capture only occurred efficiently at wall shear stress below 0.1 Pa if platelet P-selectin was blocked. If neutrophils were perfused over immobilised human IgG, many adhered at 0.025 or 0.05 Pa, but not at 0.1 Pa. Adhesion was reduced by blockade of CD16 or CD32, but blockade of CD16 had the greater effect. When neutrophils were perfused over a combination of purified P-selectin and IgG, blockade of CD16 and CD32 inhibited activation of captured cells. Immunoglobulin deposited in tissue could capture and activate slow-flowing neutrophils. It might also potentiate inflammatory responses at higher stress if presented along with selectins. The dominant FcR for capture of neutrophils was CD16, but with murine antibody, CD32 played a greater role.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934243     DOI: 10.1016/j.cellimm.2006.07.007

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  7 in total

1.  Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms.

Authors:  N M Valenzuela; K R Trinh; A Mulder; S L Morrison; E F Reed
Journal:  Am J Transplant       Date:  2015-02-03       Impact factor: 8.086

2.  Immunoglobulin subclass determines ability of immunoglobulin (Ig)G to capture and activate neutrophils presented as normal human IgG or disease-associated anti-neutrophil cytoplasm antibody (ANCA)-IgG.

Authors:  T Pankhurst; G Nash; J Williams; R Colman; A Hussain; C Savage
Journal:  Clin Exp Immunol       Date:  2011-03-10       Impact factor: 4.330

3.  Intracapillary immune complexes recruit and activate slan-expressing CD16+ monocytes in human lupus nephritis.

Authors:  Florina Olaru; Thomas Döbel; Anke S Lonsdorf; Stephanie Oehrl; Michael Maas; Alexander H Enk; Marc Schmitz; Elisabeth F Gröne; Hermann-J Gröne; Knut Schäkel
Journal:  JCI Insight       Date:  2018-06-07

4.  Copy number, linkage disequilibrium and disease association in the FCGR locus.

Authors:  Heather A Niederer; Lisa C Willcocks; Tim F Rayner; Wanling Yang; Yu Lung Lau; Thomas N Williams; J Anthony G Scott; Britta C Urban; Norbert Peshu; Sarah J Dunstan; Tran Tinh Hien; Nguyen Hoan Phu; Leonid Padyukov; Iva Gunnarsson; Elisabet Svenungsson; Caroline O Savage; Richard A Watts; Paul A Lyons; David G Clayton; Kenneth G C Smith
Journal:  Hum Mol Genet       Date:  2010-05-27       Impact factor: 6.150

5.  Cross-linking of IgGs bound on circulating neutrophils leads to an activation of endothelial cells: possible role of rheumatoid factors in rheumatoid arthritis-associated vascular dysfunction.

Authors:  Emmanuelle Rollet-Labelle; Myriam Vaillancourt; Louis Marois; Marianna M Newkirk; Patrice E Poubelle; Paul H Naccache
Journal:  J Inflamm (Lond)       Date:  2013-07-31       Impact factor: 4.981

Review 6.  Genetic Variation in Low-To-Medium-Affinity Fcγ Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine.

Authors:  Sietse Q Nagelkerke; David E Schmidt; Masja de Haas; Taco W Kuijpers
Journal:  Front Immunol       Date:  2019-10-03       Impact factor: 7.561

7.  Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake.

Authors:  Lisa C Willcocks; Paul A Lyons; Menna R Clatworthy; James I Robinson; Wanling Yang; Stephen A Newland; Vincent Plagnol; Naomi N McGovern; Alison M Condliffe; Edwin R Chilvers; Dwomoa Adu; Elaine C Jolly; Richard Watts; Yu Lung Lau; Ann W Morgan; Gerard Nash; Kenneth G C Smith
Journal:  J Exp Med       Date:  2008-06-16       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.